SCHEMBL7484017

SCHEMBL7484017

CC(=O)Oc1c(C(=O)c2ccc3c(c2)OCCO3)[nH]c2cc(Cl)ccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCB11 O95342 1/20 0.43
▸ NPC1 O15118 5/20 0.42
▸ RAB9A P51151 5/20 0.42
▸ POLB P06746 2/20 0.42
▸ ATM Q13315 1/20 0.42
▸ RXFP1 Q9HBX9 1/20 0.42
▸ MAOB P27338 3/20 0.42
▸ MAPT P10636 3/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ KDM4E B2RXH2 2/20 0.41
▸ MEN1 O00255 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7482672 0.94 MEN1 (0.47) ABCB11NPC1RAB9APOLBMAOB
SCHEMBL7479527 0.89 ABCB11 (0.40) ABCB11NPC1RAB9ATUBB4ATUBB
SCHEMBL27554521 0.86 ABCB11 (0.52) ABCB11TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL27531753 0.83 ABCB11 (0.47) ABCB11TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL27554921 0.83 ABCB11 (0.49) ABCB11TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL8120167 0.83 ABCB11 (0.49) ABCB11TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL8137639 0.83 ABCB11 (0.49) ABCB11TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL8139610 0.82 ABCB11 (0.48) ABCB11NPC1RAB9AMEN1KMT2A
SCHEMBL8136391 0.82 HPGD (0.51) ABCB11RAB9APOLBMAPTTUBB4A
SCHEMBL8134012 0.82 ABCB11 (0.48) ABCB11TUBB4ATUBBTUBA3CTUBA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1065204-B1 Bicycliccarbonyl indole compounds as anti-inflammatory/analgesic agents and as COX-2 inhibitors PFIZER (US) 2002-04-10 — — EP disclosed
US-6303628-B1 FOR THE TREATMENT OF A MEDICAL CONDITION IN WHICH PROSTAGLANDINS ARE IMPLICATED AS PATHOGENS IN MAMMALS PFIZER INC 2001-10-16 — — US disclosed
EP-1065204-A1 Bicycliccarbonyl indole compounds as anti-inflammatory/analgesic agents and as COX-2 inhibitors PFIZER INC. (US) 2001-01-03 — — EP disclosed
Send feedback